CCDC60 and neoplasm: Based on the analysis of cancer stage, lymph node metastasis status, tumor grade, patients’ gender, age and TP53 status, CCDC60 expression was significantly downregulated in different subgroup of HNSC patients (P < 0.05, Figures 1F–K).